Trial Profile

Cerebrolysin and Repetitive Transcranial Magnetic Stimulation (Rtms) in Patients with Traumatic Brain Injury

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 01 Mar 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs FPF 1070 (Primary)
Indications Traumatic brain injuries
Focus Therapeutic Use
Acronyms CAPTAIN-rTMS

Most Recent Events

13 Dec 2021 Planned End Date changed from 31 May 2022 to 28 Feb 2022.
28 Feb 2020 Planned End Date changed from 31 Dec 2020 to 31 May 2022.
26 Feb 2019 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com